m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00167
|
[1], [2] | |||
: m6A sites
Direct
Inhibition
RNA modification
HNF4A
HNF4A
ADARB1
Methylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | |||
| m6A Target | Double-stranded RNA-specific editase 1 (ADARB1) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> Adenosine-to-Inosine editing (A-to-I) | ||||
| Epigenetic Regulator | Double-stranded RNA-specific editase 1 (ADARB1) | WRITER | View Details | ||
| Regulated Target | Hepatocyte nuclear factor 4 alpha (HNF4A) | View Details | |||
| Crosstalk Relationship | m6A → A-to-I | Inhibition | |||
| Crosstalk Mechanism | m6A modification directly impacts RNA modification through modulating the expression level of RNA modification regulator | ||||
| Crosstalk Summary | YTHDF2 recognizes the m6A methylation sites and prevents Double-stranded RNA-specific editase 1 (ADARB1) dependent A-to-I RNA editing of Hepatocyte nuclear factor 4 alpha (HNF4A). | ||||
| Responsed Drug | BI6015 | ||||
In-vitro Model |
A-172 | Glioblastoma | Homo sapiens | CVCL_0131 | |
| HepaRG | Hepatitis C infection | Homo sapiens | CVCL_9720 | ||
Full List of Potential Compound(s) Related to This m6A-centered Crosstalk
| Hepatocyte nuclear factor 4 alpha (HNF4A) | 3 Compound(s) Regulating the Target | Click to Show/Hide the Full List | ||
| BI6015 | Investigative | [3] | ||
| Synonyms |
BI 6015; BI-6015
Click to Show/Hide
|
|||
| MOA | Antagonist | |||
| External Link | ||||
| Lauric Acid | Investigative | [4] | ||
| Synonyms |
DODECANOIC ACID; 143-07-7; n-Dodecanoic acid; Dodecylic acid; Vulvic acid; Laurostearic acid; Dodecoic acid; Duodecylic acid; 1-Undecanecarboxylic acid; Aliphat No. 4; Neo-fat 12; C12 fatty acid; Ninol AA62 Extra; Wecoline 1295; Neo-fat 12-43; Hydrofol acid 1295; Hydrofol acid 1255; Duodecyclic acid; Hystrene 9512; Dodecylcarboxylate; Lauric acid (natural); Univol U-314; Lauric acid, pure; Coconut oil fatty acids; ABL; Undecane-1-carboxylic acid; Laurinsaeure; NSC-5026; CCRIS 669; C-1297; UNII-1160N9NU9U; n-Dodecanoate
Click to Show/Hide
|
|||
| MOA | Inhibitor | |||
| External Link | ||||
| MYRISTIC ACID | Investigative | [5] | ||
| Synonyms |
Tetradecanoic acid; 544-63-8; n-Tetradecanoic acid; n-Tetradecoic acid; Crodacid; n-Tetradecan-1-oic acid; 1-Tridecanecarboxylic acid; Univol U 316S; Hydrofol acid 1495; Emery 655; Myristinsaeure; Myristate; tetradecoic acid; Hystrene 9014; Neo-fat 14; Myristic acid (natural); C14 fatty acid; Myristic acid, pure; n-Myristic acid; Tetradecanoate; acide tetradecanoique; NSC 5028; FEMA No. 2764; CCRIS 4724; CH3-[CH2]12-COOH; HSDB 5686; UNII-0I3V7S25AW; Philacid 1400; CHEBI:28875; AI3-15381; Prifac 2942; C14:0; EINECS 208-875-2
Click to Show/Hide
|
|||
| MOA | Inhibitor | |||
| External Link | ||||
References
: m6A sites
: modification sites